ArticleOpen forum infectious diseases2024

Real-world Experience of Posaconazole Therapeutic Drug Monitoring in Oncology Patients: Clinical Implications of Hypoalbuminemia as a Predictor of Subtherapeutic Posaconazole Levels.

Guy Handley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.